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ABSTRACT 2 
Objectives 3 
To develop and validate a surgical performance indicator based on severe urinary 4 
complications that require an intervention within two years after radical prostatectomy (RP) 5 
identified in hospital administrative data. 6 
Patients and Methods 7 
Men who underwent RP between 2008 and 2012 in England were identified using hospital 8 
administrative data. A transparent coding-framework based on procedure codes was 9 
developed to identify severe urinary complications which were grouped into “stricture”, 10 
“incontinence” and “other”. Their validity as a performance indicator was assessed by 11 
evaluating the consistency with diagnosis codes and association with patient and surgical 12 
characteristics. Kaplan-Meier methods were used to assess time to first occurrence and 13 
multivariable logistic regression to estimate adjusted odds ratios (OR) for patient and 14 
surgical characteristics. 15 
Results 16 
17,299 men were included, 2,695 (15.6%) experienced at least one severe urinary 17 
complication within two years. High proportions of men with a complication had relevant 18 
diagnosis codes: 86% for strictures and 93% for incontinence. Urinary complications were 19 
more common in men from poorer socio-economic backgrounds(OR comparing lowest with 20 
highest quintile: 1.45; 95%CI, 1.26-1.67) and those with prolonged length of hospital stay 21 
(OR 1.54, 95% CI, 1.40-1.69) and were less common in men who had robotic surgery (OR 22 
0.65, 95% CI, 0.58-0.74). 23 
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Conclusion 24 
These results demonstrate severe urinary complications identified in administrative data 25 
provide a medium-term performance indicator after RP. They can be used for research 26 
assessing outcomes of treatment modalities and for service evaluation comparing 27 
performance of prostate cancer surgery providers.  28 
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INTRODUCTION 29 
Men undergoing radical prostatectomy (RP) for prostate cancer (PCa) may experience 30 
treatment-related urinary complications. Their occurrence may reflect the quality of surgical 31 
care(1) but it is essential to demonstrate that they provide a valid outcome measure before 32 
they are used as an indicator of surgical performance. 33 
Studies using administrative datasets have reported the incidence of complications after 34 
PCa treatment in the United States, England and Canada (2-6). However, none define a 35 
coding system to identify these complications explicitly or assess their validity as a 36 
performance indicator. 37 
In this study, a transparent coding-framework is proposed based on procedure codes to 38 
identify complications severe enough to require a hospital readmission for a surgical 39 
procedure. Comparisons with relevant diagnosis codes were performed to demonstrate 40 
coding consistency. Further validation assessed the timing of these procedures and 41 
association with patient characteristics, including age, comorbidity, socioeconomic 42 
deprivation, and surgical characteristics, including length of hospital stay post-RP and 43 
surgical approach used.  44 
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PATIENTS& METHODS 45 
Patient population 46 
The Hospital Episode Statistics (HES) database, an administrative database of all admissions 47 
to hospitals of the National Health Service in England was used to identify patients who 48 
underwent RP between 1 January 2008 and 31 December 2012. HES records contain a 49 
unique patient identifier that allows for longitudinal follow-up(7). Diagnoses are coded using 50 
the International classification of Diseases, 10th revision (ICD-10)(8) and procedures are 51 
coded using the UK Office for Population Census and Surveys classification, 4th revision 52 
(OPCS-4)(9).Inpatient HES records were linked to the English National Cancer Data 53 
Repository (NCDR) to verify the diagnosis of PCa (10). 54 
Data items in HES records were used to determine age, Charlson comorbidity score (11), 55 
socioeconomic deprivation status (12),length of hospital stay post-RP and the surgical 56 
approach used (Appendix, Table 1 for detailed description of coding-framework). 57 
 58 
Inclusion and exclusion criteria 59 
The records of 18,761 men with a procedure code for RP (OPCS-4 “M61”) were studied. 60 
Patients were excluded if they did not have a matching NCDR record (n=22), if they could 61 
not be linked to one of the 48 regional hubs providing RP (n=345) or if we could not 62 
determine their socioeconomic deprivation status according to the national ranking from 63 
the Index of Multiple Deprivation (n=41) (12) (Figure 1). 64 
 65 
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Men with an associated diagnosis of bladder cancer (n=229, ICD-10 “C61”) were excluded as 66 
their surveillance often requires interval cystoscopies which could be incorrectly captured as 67 
a treatment of a complication of RP.  Men who received adjuvant or salvage radiotherapy 68 
(n=825) were excluded because it is not possible to distinguish between complications that 69 
occurred as a consequence of RP or radiotherapy (OPCS-4 codes defined in Appendix, Table 70 
1). As a result, we included 17,299 men for whom we had complete data and at least two 71 
years of follow-up (Figure 1). 72 
 73 
Technical coding 74 
All HES records of readmissions two years after RP were examined to identify medium-term 75 
urinary complications(2).This 2-year follow-up period was chosen as a preliminary time-to-76 
event analysis demonstrated that 80% of men who experienced a severe urinary 77 
complication within 5 years following RP had experienced the complication within the first 2 78 
years. Therefore, to standardise our outcome measure we report urinary complications 79 
within 2 years of RP. 80 
Based on earlier studies, a comprehensive index list of OPCS-4 procedure codes related to 81 
urinary complications after RP was pre-specified (“forward-coding”) (2-4, 6). We also 82 
examined the most frequently occurring procedure codes in records of readmissions and 83 
added these to the pre-specified list if they were not already included but likely to be 84 
related to urinary complications (“backward-coding”). These specified procedure codes 85 
were further stratified into those related to the treatment of a “stricture” or “urinary 86 
incontinence”. Procedure codes not clearly related to either complication were labelled as 87 
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“other”. Importantly, HES records never included both stricture and incontinence 88 
procedures in the same readmission. 89 
If more than one relevant procedure code related to a specific urinary complication was 90 
present in a readmission record, the first procedure code in the record was used. Based on 91 
the above coding rules, the frequency of readmissions was separated according to type of 92 
urinary complication and by specific OPCS-4 procedures codes (Table 2). 93 
Patients were considered as not having experienced a severe urinary complication if there 94 
were no hospital readmissions in the first two years after RP or if there were no relevant 95 
procedure codes in the first seven procedural fields of a readmission. 96 
 97 
Coding consistency 98 
We assessed whether consistent diagnostic codes were present in the first seven diagnosis 99 
fields in records of episodes that contained procedure codes for treatment of a stricture or 100 
urinary incontinence. An index list of diagnosis codes for stricture or urinary incontinence 101 
was generated according to the ICD-10 classification using the forward-coding approach 102 
(Appendix, Table 2). 103 
 104 
Statistical analysis 105 
Kaplan-Meier curves were used to assess the time to the first occurrence of a stricture, 106 
incontinence or “other” severe urinary complication or to the first occurrence of any of 107 
these complications. 108 
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Multivariable logistic regression modelling was used to assess the impact of patient (age, 109 
comorbidity, socioeconomic deprivation status) and surgical characteristics (length of stay 110 
and surgical approach) on the occurrence of a urinary complication in the first two years 111 
after RP as defined above. Results are reported as odds ratios and a p-value smaller than 112 
0.05 was considered statistically significant. P-values were based on the Wald test or the 113 
likelihood ratio test as appropriate. 114 
A funnel plot for any medium-term severe urinary complication was generated to assess 115 
whether the study outcome measure could be used as a performance indicator comparing 116 
the proportion of patients with one or more complication across 48 specialist hubs that 117 
provide RP in England (13). Risk adjustment was performed to account for possible 118 
differences in case-mix using indirect standardisation whereby a standardised event ratio 119 
was obtained for each provider by dividing the observed by the expected number of 120 
complications(14). The adjusted rate for a provider was generated by multiplying this 121 
standardised event ratio by the national average complication rate. The expected number of 122 
complications was estimated with the multivariable logistic regression model adjusting for 123 
covariates as described earlier. The funnel plot was generated using two-sided control limits 124 
defining differences corresponding to two standard deviations (inner limits) and three 125 
standard deviations (outer limits) from the national average complication rate. If a 126 
provider’s “true” complication rate is the same as the national rate, the probability that the 127 
adjusted complication rate for this provider will fall outside the funnel is 5% for the inner 128 
control limits and 0.2% for the outer control limits. Stata® version 14 (StataCorp, College 129 
Station, Texas, USA) was used for all statistical calculations.  130 
9 
 
RESULTS 131 
Patient population 132 
Approximately 60% of the 17,299 men included were between 60 and 69 years old, one in 133 
seven had at least one recorded comorbidity, and one in three stayed in hospital for longer 134 
than three days post-RP(Table 1).During the study period, open-RP was the most commonly 135 
used (39.7%) and robotic the least commonly used surgical approach (28.6%).  136 
 137 
Frequency of severe urinary complications 138 
2,695 men (15.6%) experienced at least one severe urinary complication within two years of 139 
RP. These men required 3,609 readmissions for complication-related procedures (1.3 140 
readmissions/man) (Table 2). The most frequent complication-related procedure (1,436 of 141 
3,609 complications, 39.8%) was an “unspecified endoscopic examination of the bladder”. 142 
The most frequent procedure for strictures (408 of 1567 complications, 26.0%) was 143 
“endoscopic incision of outlet of male bladder” and for incontinence (143 of 149 144 
complications, 96.0%) was “implantation of an artificial urinary sphincter”. 145 
 146 
Type and timing of urinary complications 147 
Within two years of RP, 6.5% of men had experienced at least one recorded readmission 148 
with a treatment code related to a stricture, 0.8% related to incontinence and 11.5% of men 149 
related to “other” complications (Figure 2). The treatment codes related to these “other” 150 
complications could be grouped into cystoscopy (1,159 out of 1860 readmissions [62.3%]) 151 
and procedures addressing catheter problems (701 out of 1860 readmissions [37.7%]), 152 
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based on first occurring complication (Appendix, Figure 1). Approximately two thirds of men 153 
experienced a severe urinary complication within the first six months after RP (1,712 out of 154 
2,695 [63.5%]) (Figure 3).  155 
 156 
Coding consistency 157 
There was high degree of consistency between the OPCS-4 codes used to capture 158 
procedures related to urinary complications and ICD-10 diagnosis codes for strictures and 159 
urinary incontinence in the records of readmission episodes. A consistent diagnosis code 160 
was observed for 1,350 out of 1,567 (86%) of records that contained a procedure code 161 
related to a stricture and for 138 out of 149 (93%) of records that related to incontinence. 162 
 163 
Association with patient and surgical characteristics 164 
Multivariable analysis demonstrated that the occurrence of at least one complication in the 165 
first two years after RP was significantly lower in those from more affluent socioeconomic 166 
backgrounds, in those who stayed three days or less in hospital following RP, and in those 167 
who had a robotic approach (Table 3). The univariable analysis also demonstrated significant 168 
associations between the year in which RP was carried out, the patient’s age, comorbidity 169 
status and the occurrence of urinary complications but these associations were no longer 170 
observed in the multivariable analysis, adjusting for other patient characteristics and 171 
treatment factors. 172 
A risk-adjusted funnel plot was generated for two-year rates of any severe urinary 173 
complication in each of the 48 regional PCa surgery providers (Figure 4). Ten of the 174 
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48providers were located outside the outer limits of the funnel (five above the upper and 175 
five below the lower outer limit).  176 
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DISCUSSION 177 
A transparent coding-framework was developed to identify severe urinary complications 178 
after RP within English hospital administrative data. Because the coding-framework is solely 179 
based on procedure codes it includes complications severe enough to require a readmission 180 
to hospital. We demonstrated that the rate of complications identified in this way appears 181 
to be a valid indicator of surgical performance of RP providers given the consistency with 182 
relevant diagnosis codes, the anticipated pattern of the timing of these complications, and 183 
the association with treatment factors which have been reported to be linked to surgical 184 
complications. When this two-year complication rate was used as an indicator of the 185 
performance of PCa surgery providers we found a pattern often reported for other 186 
established surgical indicators (15). 187 
 188 
Methodological considerations 189 
We developed a comprehensive coding list that reflects current coding practice by using 190 
both a forward and a backward-coding approach. Using this methodology we were able to 191 
demonstrate that 86% of stricture-related complications and 93% of incontinence-related 192 
procedures had appropriate diagnosis codes. This high level of compatibility in operative 193 
and diagnostic coding validates our approach and is comparable to that reported in other 194 
published studies using administrative data (16). 195 
Procedure codes were used in preference to diagnosis codes for two reasons. First, there is 196 
evidence that the accuracy of procedural coding is greater than diagnostic coding within 197 
administrative data (17). Second, the use of procedure codes ensured only complications 198 
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severe enough to require hospital-based treatments were captured. In this way, we avoided 199 
“overestimation” of the complication rate, a recognised problem when diagnosis codes are 200 
used for this purpose(18). 201 
Multivariable modelling corroborated the associations between patient/surgical 202 
characteristics and urinary complications previously reported in the literature. Men who 203 
stayed in hospital three days or less after surgery and those who underwent a robotic-RP 204 
were found to be significantly less likely to experience a severe urinary complication, as 205 
reported in other studies(19-21). We also found that the complication rate was affected by 206 
the patient’s socioeconomic background which corresponds with earlier observations in 207 
men who underwent RP in the English National Health Service (NHS) between 1997 and 208 
2004(5). 209 
The observed timing of the different types of complications reflects what can be expected 210 
based on pathophysiological considerations. For example, most severe urinary 211 
complications that occurred within the first month after surgery were recognised as “other” 212 
complications (i.e. those that were not grouped into stricture or incontinence) and they 213 
consisted of unplanned cystoscopies and procedures related to catheter problems. We 214 
found that stricture-related treatments occurred after the immediate post-operative period 215 
and increased steadily thereafter in keeping with the physiological process of stricture 216 
formation. Interventions for incontinence were rare in the first two years after RP with less 217 
than 1% requiring a procedure, consistent with earlier observations (22). 218 
We used a classification system for procedures (OPCS-4) that is only currently used for 219 
hospital administrative data in the UK. This implies that the proposed indicator can only be 220 
applied in other health systems after the coding-framework presented in the current study 221 
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has been “translated” for other procedure coding classification systems. We however 222 
expect that this will have minimal effect on the validity of the surgical performance indicator 223 
presented in the current study. A number of different procedural classification systems are 224 
employed to code for procedures within datasets of a number of different countries. For 225 
example, in the US the Healthcare Common Procedure Coding System (HCPS) is used to 226 
code for operative procedures whereas in Canada, the Canadian classification of Diagnostic, 227 
Therapeutic, and Surgical procedures is employed. By using the backward coding approach 228 
presented in the current study, local coding practice within these different procedure coding 229 
systems can be determined and as such a similar surgical performance indicator to that 230 
presented in the current study can be developed. 231 
A limitation of using procedure codes as a surrogate for urinary complications is that 232 
patients who were symptomatic but did not undergo an intervention for their symptoms are 233 
not captured and so absent from our analysis. We were not able to identify this cohort of 234 
patients and as such the overall burden of urinary complications is likely to be an 235 
underestimate, particularly for urinary incontinence. A further limitation is that we were not 236 
able to externally validate our study indicator using clinical records. Nonetheless we feel 237 
that the transparent coding framework and step-wise internal validation used to develop 238 
the study indicator, a process which is lacking in other studies using administrative 239 
database, justifies its validity as a surgical performance indicator. 240 
 241 
Comparison with other studies 242 
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Two recent studies used physician billing codes to determine a list of “urologic minimally 243 
invasive procedures” which acted as a surrogate for urinary complications (2, 6). These 244 
studies focussed on differences in outcome between men undergoing RP versus 245 
radiotherapy. In contrast to the present study, these studies did not provide a transparent 246 
coding-framework nor did they assess the validity of this outcome as a performance 247 
indicator. Earlier studies carried out in the US (3), Canada (4) and England (5)(6) used 248 
diagnosis codes solely or in combination with procedure codes which may lead, as indicated 249 
above, to overestimation of the complication rates(18). 250 
 251 
 252 
Applicability of study performance indicator 253 
Using a funnel plot, we found that the proportion of patients who experienced a severe 254 
urinary complication according to our performance indicator was distributed among the 48 255 
regional providers of RP in England as could be expected based on results of comparisons of 256 
other outcomes of urological cancer treatment across secondary care providers (15). This 257 
provides further support that severe urinary complications identified in administrative data 258 
can be used to assess variation in surgical performance. This is of particular relevance in the 259 
UK NHS where initiatives such as the National Prostate Cancer Audit (NPCA)(23) exist to 260 
evaluate variation in the quality of prostate cancer surgery. The surgical performance 261 
indicator presented in the current study will be used alongside other outcome metrics 262 
including Patient Reported Outcome Measures (PROMs) to provide an overall assessment of 263 
the quality of prostate cancer surgical care in England. While we were not able to reliably 264 
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identify the operating surgeon using our existing database; it is envisaged that further data-265 
linkage within the NPCA will allow surgeon-level reporting in the future. Moreover, given 266 
the rapid diffusion of robotic RP, this outcome measure has the potential to be used to 267 
compare the medium-term outcomes of different approaches to RP. 268 
 269 
Conclusions 270 
The current study provides a transparent coding-framework to capture severe urinary 271 
complications in the first two years after radical prostatectomy in hospital administrative 272 
data. These complications can be used as a performance indicator for service evaluation and 273 
research.  274 
 275 
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Table 1: Patient and surgical characteristics of men undergoing  288 
radical prostatectomy (RP) (2008 – 2012) 289 
 290 
      291 
 292 
No. of men receiving RP 17,299 293 
 294 
Year of RP (%) 295 
 2008  2,004 (11.6) 296 
2009  3,501 (20.2) 297 
2010  3,694 (21.4) 298 
 2011  4,002 (23.1) 299 
 2012  4,098 (23.7) 300 
 301 
Age (%) 302 
 <60  5,391 (31.2) 303 
 60-69  10,117 (58.5) 304 
 >70  1,791 (10.4) 305 
 306 
Charlson comorbidity score (%) 307 
 0  14,382(83.1) 308 
 ≥1  2,917 (16.9) 309 
 310 
Socioeconomic deprivation (%) 311 
 1(least)  4,432 (25.6) 312 
 2  4,239 (24.5) 313 
 3  3,590 (20.8) 314 
 4  2,888 (16.7) 315 
 5 (most)  2,150 (12.4) 316 
    317 
Length of stay post RP (days) (%) 318 
≤3  11,597 (67.0) 319 
>3   5,702 (33.0) 320 
 321 
RP surgical approach (%) 322 
 Open  6,873 (39.7) 323 
 Laparoscopic 5,479 (31.7) 324 
 Robotic  4,949 (28.6) 325 
 326 
      327 
 328 
 329 
 330 
 331 
 332 
 333 
 334 
 335 
 336 
 337 
 338 
 339 
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Table 2: Frequency of readmissions for treatment-related complications within two years of 340 
radical prostatectomy 341 
 342 
OPCS-4 code Description Total 
readmissions  
 
M44.8/9 Other endoscopic operations on bladder 27 “Other” 
urinary 
complication 
M45.5 Examination of bladder using rigid cystoscope 79 
M45.8 Other specified endoscopic examination of bladder 30 
M45.9 Unspecified endoscopic examination of bladder 1,436 
M47.1 Urethral irrigation of bladder 150 
M47.8/9 Other specified urethral catheterisation of bladder 171 
M48.1 Suprapubic aspiration of bladder 3 Stricture-
related 
complication 
M64.8 Other specified open operations on outlet of male 
bladder 
28 
M65.1-5 Endoscopic resection of prostate  13 
M65.8/9 
M66.9 
Other specified endoscopic resection of outlet of 
male bladder 
13 
M66.2 Endoscopic incision of outlet of male bladder 408 
M66.8 Other specified therapeutic endoscopic operations 
on outlet of male bladder 
115 
M76.3 Optical urethrotomy 388 
M76.4 Endoscopic dilation of urethra 368 
M76.8/9 Other therapeutic endoscopic operations on 
urethra 
5 
M79.2 Dilation of urethra  202 
M79.4 Internal urethrotomy  24 
M64.2 Implantation of artificial urinary sphincter into outlet 
of male bladder 
143 Incontinence-
related 
complication M64.3 Insertion of prosthetic collar around outlet of male 
bladder 
4 
M64.6 Reconstruction of neck of male bladder  2 
 Total 3,609  
 343 
 344 
 345 
 346 
 347 
 348 
 349 
 350 
 351 
 352 
 353 
 354 
 355 
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Table 3: Relationship between patient and surgical characteristics and occurrence of at least one urinary complication following radical 356 
prostatectomy (RP) 357 
 358 
                359 
 360 
 361 
Patient Characteristics No. of men with a  Unadjusted OR    Adjusted OR*    362 
   Urinary complication (%) (95% CI)   p  (95% CI)                     p    363 
                 364 
Year of RP 365 
2008   349 (17.4)  1.0   <0.01  1.0   0.08 366 
2009   633 (18.1)  1.05 (0.91-1.21)    1.12 (0.97-1.29) 367 
2010   581 (15.7)  0.89 (0.77-1.02)    1.00 (0.87-1.17) 368 
2011   578 (14.4)  0.81 (0.69-0.93)    0.98 (0.84-1.13) 369 
2012   554 (13.5)  0.74 (0.64-0.86)    0.94 (0.81-1.09) 370 
 371 
Age 372 
<60   823 (15.3)  1.0   0.04  1.0   0.11 373 
60-69   1555 (15.4)  1.01 (0.92-1.10)    0.99 (0.90-1.09) 374 
≥70   317 (17.7)  1.19 (1.04-1.38)    1.14 (0.99-1.32) 375 
 376 
Charlson comorbidity score 377 
0   2196 (15.3)  1.0   0.01  1.0   0.18 378 
≥1   499 (17.1)  1.15 (1.03-1.27)    1.08 (0.97-1.20) 379 
 380 
Socioeconomic deprivation   381 
1(least)   580 (13.1)  1.0   <0.01  1.0   <0.01 382 
2   661 (15.6)  1.23 (1.09-1.38)    1.18 (1.04-1.33) 383 
3   528 (14.7)  1.15 (1.01-1.30)    1.07 (0.94-1.22) 384 
4   506 (17.5)  1.41 (1.24-1.60)    1.32 (1.15-1.50) 385 
5(most)   420 (19.5)  1.61 (1.40-1.85)    1.45 (1.26-1.67) 386 
 387 
Length of stay 388 
≤3   1497 (12.9)  1.0   <0.01  1.0   <0.01 389 
>3   1198 (21.0)  1.79 (1.65-1.95)    1.54 (1.40-1.70) 390 
 391 
RP surgical approach  392 
Open   1309 (19.1)  1.0   <0.01  1.0   <0.01 393 
Laparoscopic   866 (15.8)  0.79 (0.73-0.88)    0.98 (0.88-1.08) 394 
Robotic-assisted  520 (10.5)  0.50 (0.45-0.56)    0.65 (0.58-0.74) 395 
 396 
                397 
CI= confidence interval 398 
*Odds Ratio derived using multivariable logistic regression 399 
  400 
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Figure 1: Flow chart of men included in study 401 
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 437 
 438 
Matched to regional providers of prostate cancer 
Surgery 
18,353 
 
Missing Data Exclusions (n=386): 
 345 men excluded not matched to regional provider 
 41 men excluded with missing deprivation status 
 
 
 
24,165 
 
Final cohort 
17,299 
 
Clinical Exclusions (n=1,054) 
 229 men excluded with additional diagnosis of 
bladder cancer 
 825 men excluded who received adjuvant 
radiotherapy 
 
 
 
Men undergoing radical prostatectomy from    
2008 – 2012  
in Hospital Episodes Statistics (HES) 
18,761 
22 men excluded without matching 
National Cancer Data Repository (NCDR) 
record  
Men undergoing radical prostatectomy from             
2008 – 2012  
with HES linked National Cancer Repository records 
18,739 
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Figure 2: Kaplan-Meier curves for urinary complications according to type of complication 439 
 440 
 441 
Figure 3: Kaplan-Meier curve for any urinary complication following radical prostatectomy  442 
 443 
 444 
 445 
 446 
 447 
 448 
 449 
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Figure 4: Risk-adjusted funnel plot of any urinary complication in  48 regional providers of 450 
prostate cancer surgery in England 451 
 452 
 453 
 454 
 455 
 456 
 457 
 458 
 459 
 460 
 461 
 462 
 463 
 464 
 465 
 466 
 467 
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Supplementary Files & Data 468 
Appendix 469 
Table 1: OPCS-4 and ICD-10 codes used to identify men receiving adjuvant radiotherapy and 470 
type of radical prostatectomy approach.  471 
Procedure Description OPCS-4 codes ICD-10 codes 
Adjuvant 
Radiotherapy 
X65, X67, Y91, Y92 Y842, Z0081, Z091, Z510, Z58, Z923 
Robotic-assisted 
Prostatectomy 
Y753, Y765 - 
Laparoscopic 
Prostatectomy 
Y752, Y768, Y763, Y751, Y508 - 
 472 
Figure 1: Treatment codes associated with first occurring urinary complication according to 473 
type of urinary complication. 474 
 475 
 476 
Table 2: ICD-10 codes used to identify diagnoses of a stricture and incontinence 477 
ICD-10 Diagnosis Codes Description of diagnosis 
N320 N35, N991, R33 Stricture-related 
 
N393, N394, N398, R32 Incontinence-related 
  478 
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